Successfully treated necrotizing fasciitis using extracorporeal life support combined with hemoadsorption device and continuous renal replacement therapy by M. Eid et al.
Successfully treated necrotizing fasciitis using
extracorporeal life support combined with hemoadsorption
device and continuous renal replacement therapy
Submitted by Beatrice Guillaumat on Tue, 06/04/2019 - 11:22
Titre Successfully treated necrotizing fasciitis using extracorporeal life support combinedwith hemoadsorption device and continuous renal replacement therapy
Type de
publication Article de revue
Auteur Eid, Maroua [1], Fouquet, Olivier [2], Darreau, Cédric [3], Pierrot, Marc [4],Kouatchet, Achille [5], Mercat, Alain [6], Baufreton, Christophe [7]
Editeur Sage Journals








revue The International Journal of Artificial Organs
ISSN 1724-6040
Mots-clés
Adult [8], Extracorporeal Membrane Oxygenation [9], Fasciitis, Necrotizing [10],
Hemodynamics [11], Humans [12], Life Support Care [13], Male [14], Multiple Organ




INTRODUCTION: Necrotizing fasciitis represents a life-threatening infectious
condition that causes spreading necrotisis of superficial fascia and subcutaneous
cellular tissues. We describe the case of a patient diagnosed with septic and toxic
shocks leading to multiple organ failure successfully treated with a combination of
extracorporeal life support, continuous renal replacement therapy, and a
hemoadsorption device.
METHODS: A 41-year-old patient presented with necrotizing fasciitis and multi-organ
failure. Initial extracorporeal life support therapy was implanted, compensating for
systolic failure. Due to acute renal failure that persisted in time, continuous renal
replacement therapy was added. Despite these treatments and as a last attempt to
control the septic condition, a CytoSorb hemoadsorption device was installed in
parallel to the extracorporeal life support circuit and two sessions were run.
RESULTS: During the days following CytoSorb treatment, hemodynamic stabilization
was observed, as well as normalization of lactic acidosis and blood parameters.
CONCLUSION: This case describes the successful use of CytoSorb with continuous
renal replacement therapy and extracorporeal life support in a combined way to
overcome a critical phase of septic shock in a young adult patient. This combination of
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